Skip to main content
Premium Trial:

Request an Annual Quote

Biomarker Strategies: Greg Bertenshaw

Biomarker Strategies has promoted Greg Bertenshaw to the position of chief operating and science officer. Bertenshaw was formerly vice president of R&D and director of R&D for the company, which he joined in 2011 as a senior scientist. Bertenshaw has also previously served as director of new technology for Correlogic Systems, and as a scientist and director of science for Clearant. He holds a PhD in biochemistry and molecular biology from Penn State University College of Medicine.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.